PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAlexza Pharmaceuticals
Alexza Pharmaceuticals(ALXA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AdasuveLoxapine2012-12-212024-2026
Schizophrenia
,
Psychotic disorders
,
Bipolar disorder
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Loxapine
cardiotoxicity
,
asthma
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
cigarette smoking
,
migraine disorders
,
headache
,
schizophrenia
,
psychomotor agitation
,
bipolar disorder
,
healthy volunteers/patients
Tozadenant
renal cell carcinoma
,
prostatic neoplasms
,
pancreatic neoplasms
,
non-small-cell lung carcinoma
,
triple negative breast neoplasms
,
head and neck neoplasms
,
non-hodgkin lymphoma
,
lymphoma
,
melanoma
,
large b-cell lymphoma diffuse
Ademetionine
lymphoma
,
myeloid leukemia chronic-phase
,
myeloid leukemia
,
leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
pancreatic neoplasms
,
carcinoma
,
vitiligo
,
b-cell lymphoma
,
glioblastoma
,
glioma
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
colorectal neoplasms
,
breast neoplasms
,
lung neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
neoplasms
,
hidradenitis suppurativa
,
hidradenitis
,
lichen sclerosus et atrophicus
,
lichen planus
,
adenosquamous carcinoma
,
asthma
,
cholangiocarcinoma
,
polycythemia vera
,
myeloproliferative disorders
,
primary myelofibrosis
,
polycythemia
Sodium chloride
fabry disease
Arm1
neoplasms
Trinessa
breast neoplasms
Arm2
neoplasms
,
cancer pain
,
melanoma
,
oncogenes
,
thrombocytopenic purpura idiopathic
,
thrombocytopenic purpura
,
purpura
,
leukemia
,
lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
multiple myeloma
,
plasma cell neoplasms
,
rheumatoid arthritis
,
arthritis
,
inflammation
,
cachexia
,
hepatitis c
,
chronic hepatitis c
,
chronic hepatitis b
,
hepatitis
,
chronic hepatitis
,
hepatitis a
,
overweight
,
anxiety disorders
,
social phobia
,
pruritus
,
covid-19
,
hiv infections
,
infections
,
acquired immunodeficiency syndrome
,
communicable diseases
,
rhinitis
,
immunologic deficiency syndromes
,
atrial fibrillation
,
macular degeneration
,
malaria
,
vivax malaria
,
thrombocytopenia
,
inflammatory breast neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
systemic lupus erythematosus
,
cough
,
common cold
,
dyslipidemias
,
multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
sclerosis
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
atherosclerosis
,
recurrence
,
carcinoma
,
ovarian neoplasms
,
endometrial neoplasms
,
ovarian epithelial carcinoma
,
breast neoplasms
,
hypertension
,
osteoporosis
,
postmenopausal osteoporosis
,
alzheimer disease
,
hypersensitivity
,
dentin sensitivity
,
headache
,
tension-type headache
,
prostatic hyperplasia
,
hyperplasia
,
dysmenorrhea
,
mumps
,
measles
,
chickenpox
,
rubella
,
spinal cord injuries
,
erectile dysfunction
,
asthma
,
chronic obstructive pulmonary disease
,
lung diseases
,
migraine disorders
,
type 2 diabetes mellitus
,
acne vulgaris
,
diabetes mellitus
,
prostatic neoplasms
,
back pain
,
hemorrhage
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use